Jagsonpal Pharmaceuticals Ltd
JAGSNPHARM
₹199.45
- ₹4.15
2.04%
Healthcare
₹0.00
(%)1D
Updated: 21 Nov 2025, 03:31:25 pm IST
Stock Score
Open Price
₹203.88
Prev. Close
₹203.60
₹198.95
Day Low
₹204.86
Day High
₹192.85
52 Week Low
₹820.10
52 Week High
Quick Bite
Price To Earnings Ratio 30.97 | Sector PE 33.39 |
PB Ratio 6.08 | Sector PB 5.83 |
EPS 6.44 | Dividend Yield 1.16 |
Today's Volume 44.997 K | 5 Day Avg. Volume 37.521 K |
PEG Ratio -16.56 | Market Cap. ₹ 1,400.00 Cr. |
News & Events
About Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
Jagsonpal Pharmaceuticals Ltd FAQs
How to Buy Jagsonpal Pharmaceuticals Ltd Share?
To purchase Jagsonpal Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Jagsonpal Pharmaceuticals Ltd (ticker symbol: JAGSNPHARM) on the trading platform provided by your broker and purchase the shares.
What's Jagsonpal Pharmaceuticals Ltd share price today?
The stock price of Jagsonpal Pharmaceuticals Ltd as of 22 Nov 2025 is ₹199.45
What is the Market Cap of Jagsonpal Pharmaceuticals Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 22 Nov 2025, Jagsonpal Pharmaceuticals Ltd (ticker symbol: JAGSNPHARM) has a market capitalisation of approximately ₹14,00,00,00,000.00
What is the PE and PB ratio of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd Ltd's price-to-book ratio as of 22 Nov 2025 is 6.08, reflecting the market's valuation compared to its asset value. As of 22 Nov 2025, the trailing twelve months P/E (price-to-earnings) ratio is 30.97, indicating the market values the company at around ₹30.97 for every ₹1 of earnings
What is the 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd Share?
Jagsonpal Pharmaceuticals Ltd Ltd (JAGSNPHARM) hit its 52-week high at ₹820.10, and its 52-week low at ₹192.85.
Begin your investment journey today